ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Malignancies with ANTI-TNFα pharmacotherapy noticed through post marketing surveillance (2017)
Pedro, Letícia Sybilla Borges; Ribeiro, Adalton Guimarães; Ribeiro, Eliane ; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRO, Letícia Sybilla Borges et al. Malignancies with ANTI-TNFα pharmacotherapy noticed through post marketing surveillance. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2017
APA
Pedro, L. S. B., Ribeiro, A. G., Ribeiro, E., & Kano, E. K. (2017). Malignancies with ANTI-TNFα pharmacotherapy noticed through post marketing surveillance. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Pedro LSB, Ribeiro AG, Ribeiro E, Kano EK. Malignancies with ANTI-TNFα pharmacotherapy noticed through post marketing surveillance. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 46 res. FCF087.[citado 2024 nov. 04 ]
Vancouver
Pedro LSB, Ribeiro AG, Ribeiro E, Kano EK. Malignancies with ANTI-TNFα pharmacotherapy noticed through post marketing surveillance. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 46 res. FCF087.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Adverse drug reactions profile of new drugs for Hepatits C (2016)
Kohatsu, Denise Yukari; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: HEPATITE C, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOHATSU, Denise Yukari e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2016
APA
Kohatsu, D. Y., Ribeiro, A. G., & Kano, E. K. (2016). Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Kohatsu DY, Ribeiro AG, Kano EK. Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF050.[citado 2024 nov. 04 ]
Vancouver
Kohatsu DY, Ribeiro AG, Kano EK. Adverse drug reactions profile of new drugs for Hepatits C. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF050.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Severe psychiatric adverse reactions related to the use of incretins (2016)
Silva, Nayara Aparecida de Oliveira; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Nayara Aparecida de Oliveira e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Severe psychiatric adverse reactions related to the use of incretins. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2016
APA
Silva, N. A. de O., Ribeiro, A. G., & Kano, E. K. (2016). Severe psychiatric adverse reactions related to the use of incretins. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Silva NA de O, Ribeiro AG, Kano EK. Severe psychiatric adverse reactions related to the use of incretins. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 29 res. FCF053.[citado 2024 nov. 04 ]
Vancouver
Silva NA de O, Ribeiro AG, Kano EK. Severe psychiatric adverse reactions related to the use of incretins. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 29 res. FCF053.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Risk of skin neoplasm related to the use of immunomodulatory abatacept (2016)
Pedro, Letícia Sybilla Borges; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: NEOPLASIAS, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRO, Letícia Sybilla Borges e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Risk of skin neoplasm related to the use of immunomodulatory abatacept. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2016
APA
Pedro, L. S. B., Ribeiro, A. G., & Kano, E. K. (2016). Risk of skin neoplasm related to the use of immunomodulatory abatacept. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Pedro LSB, Ribeiro AG, Kano EK. Risk of skin neoplasm related to the use of immunomodulatory abatacept. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 47 res. FCF090.[citado 2024 nov. 04 ]
Vancouver
Pedro LSB, Ribeiro AG, Kano EK. Risk of skin neoplasm related to the use of immunomodulatory abatacept. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 47 res. FCF090.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
New oral anticoagulants: what do their adverse drug reactions reports suggest? (2015)
Wasicovichi, Nataly Nataska; Ribeiro, Adalton Guimarães; Espósito, Silvana; Zampieri, Maria Elisa Ferreira Godinho; Oliveira, Maria de Lourdes Viúde; Peinado, Mirtes; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: ANTICOAGULANTES (EFEITOS ADVERSOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WASICOVICHI, Nataly Nataska et al. New oral anticoagulants: what do their adverse drug reactions reports suggest?. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2015
APA
Wasicovichi, N. N., Ribeiro, A. G., Espósito, S., Zampieri, M. E. F. G., Oliveira, M. de L. V., Peinado, M., & Kano, E. K. (2015). New oral anticoagulants: what do their adverse drug reactions reports suggest? Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Wasicovichi NN, Ribeiro AG, Espósito S, Zampieri MEFG, Oliveira M de LV, Peinado M, Kano EK. New oral anticoagulants: what do their adverse drug reactions reports suggest? Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 26 res. FCF047.[citado 2024 nov. 04 ]
Vancouver
Wasicovichi NN, Ribeiro AG, Espósito S, Zampieri MEFG, Oliveira M de LV, Peinado M, Kano EK. New oral anticoagulants: what do their adverse drug reactions reports suggest? Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 26 res. FCF047.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Suspected adverse drug reactions (ADRs) evolving to death related to biological drugs used in the rheumatoid arthritis (RA) treatment (2015)
Takashiro, Fernanda Leika; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: ARTRITE REUMATOIDE, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAKASHIRO, Fernanda Leika e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Suspected adverse drug reactions (ADRs) evolving to death related to biological drugs used in the rheumatoid arthritis (RA) treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2015
APA
Takashiro, F. L., Ribeiro, A. G., & Kano, E. K. (2015). Suspected adverse drug reactions (ADRs) evolving to death related to biological drugs used in the rheumatoid arthritis (RA) treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Takashiro FL, Ribeiro AG, Kano EK. Suspected adverse drug reactions (ADRs) evolving to death related to biological drugs used in the rheumatoid arthritis (RA) treatment. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 39 res. FCF073.[citado 2024 nov. 04 ]
Vancouver
Takashiro FL, Ribeiro AG, Kano EK. Suspected adverse drug reactions (ADRs) evolving to death related to biological drugs used in the rheumatoid arthritis (RA) treatment. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 39 res. FCF073.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Analysis of serious adverse drug reactions in VEGF-A inhibitors (2015)
Cavalcante, João Augusto Bianchini; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: DEGENERAÇÃO MACULAR, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALCANTE, João Augusto Bianchini e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Analysis of serious adverse drug reactions in VEGF-A inhibitors. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2015
APA
Cavalcante, J. A. B., Ribeiro, A. G., & Kano, E. K. (2015). Analysis of serious adverse drug reactions in VEGF-A inhibitors. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cavalcante JAB, Ribeiro AG, Kano EK. Analysis of serious adverse drug reactions in VEGF-A inhibitors. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 41 res. FCF078.[citado 2024 nov. 04 ]
Vancouver
Cavalcante JAB, Ribeiro AG, Kano EK. Analysis of serious adverse drug reactions in VEGF-A inhibitors. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 41 res. FCF078.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Cardiovascular adverse drug reaction profile of formoterol (2015)
Abe, Jéssica Larissa Cavalcante; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: FÁRMACOS, SISTEMA RESPIRATÓRIO (EFEITOS ADVERSOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABE, Jéssica Larissa Cavalcante e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Cardiovascular adverse drug reaction profile of formoterol. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2015
APA
Abe, J. L. C., Ribeiro, A. G., & Kano, E. K. (2015). Cardiovascular adverse drug reaction profile of formoterol. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Abe JLC, Ribeiro AG, Kano EK. Cardiovascular adverse drug reaction profile of formoterol. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 37 res. FCF070.[citado 2024 nov. 04 ]
Vancouver
Abe JLC, Ribeiro AG, Kano EK. Cardiovascular adverse drug reaction profile of formoterol. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 37 res. FCF070.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Serious adverse drug reaction of immunobiological drugs used in the treatment of psoriasis (2015)
Augusto, Caroline Capelão; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: PSORÍASE (TRATAMENTO), FÁRMACOS (EFEITOS ADVERSOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AUGUSTO, Caroline Capelão e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Serious adverse drug reaction of immunobiological drugs used in the treatment of psoriasis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2015
APA
Augusto, C. C., Ribeiro, A. G., & Kano, E. K. (2015). Serious adverse drug reaction of immunobiological drugs used in the treatment of psoriasis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Augusto CC, Ribeiro AG, Kano EK. Serious adverse drug reaction of immunobiological drugs used in the treatment of psoriasis. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 43 res. FCF081.[citado 2024 nov. 04 ]
Vancouver
Augusto CC, Ribeiro AG, Kano EK. Serious adverse drug reaction of immunobiological drugs used in the treatment of psoriasis. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 43 res. FCF081.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis (2015)
Silva, Nayara Aparecida de Oliveira; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Nayara Aparecida de Oliveira e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2015
APA
Silva, N. A. de O., Ribeiro, A. G., & Kano, E. K. (2015). Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Silva NA de O, Ribeiro AG, Kano EK. Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 32 res. FCF060.[citado 2024 nov. 04 ]
Vancouver
Silva NA de O, Ribeiro AG, Kano EK. Serious cardiovascular adverse drug reactions related to immunomodulators used in the treatment of multiple sclerosis. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 32 res. FCF060.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Assessment of safety and effectivity associated to oseltamivir therapy (2014)
Silva, Nayara Aparecida de Oliveira; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Assunto: ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Nayara Aparecida de Oliveira e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Assessment of safety and effectivity associated to oseltamivir therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2014
APA
Silva, N. A. de O., Ribeiro, A. G., & Kano, E. K. (2014). Assessment of safety and effectivity associated to oseltamivir therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Silva NA de O, Ribeiro AG, Kano EK. Assessment of safety and effectivity associated to oseltamivir therapy. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 47 res. FCF090.[citado 2024 nov. 04 ]
Vancouver
Silva NA de O, Ribeiro AG, Kano EK. Assessment of safety and effectivity associated to oseltamivir therapy. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 47 res. FCF090.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Risk of tuberculosis associated with therapy based on inhibitors of TNF-alpha (2014)
Passone, Julio Augusto de Lima; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Subjects: TUBERCULOSE, FATORES DE CRESCIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSONE, Julio Augusto de Lima e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Risk of tuberculosis associated with therapy based on inhibitors of TNF-alpha. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2014
APA
Passone, J. A. de L., Ribeiro, A. G., & Kano, E. K. (2014). Risk of tuberculosis associated with therapy based on inhibitors of TNF-alpha. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Passone JA de L, Ribeiro AG, Kano EK. Risk of tuberculosis associated with therapy based on inhibitors of TNF-alpha. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 33 res. FCF061.[citado 2024 nov. 04 ]
Vancouver
Passone JA de L, Ribeiro AG, Kano EK. Risk of tuberculosis associated with therapy based on inhibitors of TNF-alpha. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 33 res. FCF061.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Atrioventricular block associated with the first dose of fingolimod (2014)
Oliveira, Caroline Nascimento Barbosa; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Subjects: ESCLEROSE MÚLTIPLA, FÁRMACOS (EFEITOS ADVERSOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Caroline Nascimento Barbosa e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Atrioventricular block associated with the first dose of fingolimod. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2014
APA
Oliveira, C. N. B., Ribeiro, A. G., & Kano, E. K. (2014). Atrioventricular block associated with the first dose of fingolimod. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Oliveira CNB, Ribeiro AG, Kano EK. Atrioventricular block associated with the first dose of fingolimod. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 39 res. FCF073.[citado 2024 nov. 04 ]
Vancouver
Oliveira CNB, Ribeiro AG, Kano EK. Atrioventricular block associated with the first dose of fingolimod. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 39 res. FCF073.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Risk of pancreatic cancer associated with therapy based on incretins (2014)
Ramos, Marcela Castro; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Subjects: PANCREATITE, NEOPLASIAS PANCREÁTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Marcela Castro e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Risk of pancreatic cancer associated with therapy based on incretins. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2014
APA
Ramos, M. C., Ribeiro, A. G., & Kano, E. K. (2014). Risk of pancreatic cancer associated with therapy based on incretins. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Ramos MC, Ribeiro AG, Kano EK. Risk of pancreatic cancer associated with therapy based on incretins. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 28 res. FCF051.[citado 2024 nov. 04 ]
Vancouver
Ramos MC, Ribeiro AG, Kano EK. Risk of pancreatic cancer associated with therapy based on incretins. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 28 res. FCF051.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Progressive multifocal leukoencephalopaty associated to natalizumab: the importance of MRI based diagnosis in asymptomatic cases (2014)
Cardoso, Laila Guimarães; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Assunto: ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Laila Guimarães e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Progressive multifocal leukoencephalopaty associated to natalizumab: the importance of MRI based diagnosis in asymptomatic cases. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2014
APA
Cardoso, L. G., Ribeiro, A. G., & Kano, E. K. (2014). Progressive multifocal leukoencephalopaty associated to natalizumab: the importance of MRI based diagnosis in asymptomatic cases. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Cardoso LG, Ribeiro AG, Kano EK. Progressive multifocal leukoencephalopaty associated to natalizumab: the importance of MRI based diagnosis in asymptomatic cases. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 32 res. FCF060.[citado 2024 nov. 04 ]
Vancouver
Cardoso LG, Ribeiro AG, Kano EK. Progressive multifocal leukoencephalopaty associated to natalizumab: the importance of MRI based diagnosis in asymptomatic cases. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 32 res. FCF060.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs) (2013)
Padilha, Gabriel Felipe Silva; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Subjects: SEROTONINA, SISTEMA NERVOSO CENTRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PADILHA, Gabriel Felipe Silva e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2013
APA
Padilha, G. F. S., Ribeiro, A. G., & Kano, E. K. (2013). Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Padilha GFS, Ribeiro AG, Kano EK. Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs). Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 13 res. FCF021.[citado 2024 nov. 04 ]
Vancouver
Padilha GFS, Ribeiro AG, Kano EK. Analysis of psychological adverse reactions profile of the selective inibitors of the recaptation of serotonin (sirs). Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 13 res. FCF021.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Osteonecrosis of jaw in use of bisphosphonates (2012)
Fernandes, Renan; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Assunto: OSTEONECROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Renan e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Osteonecrosis of jaw in use of bisphosphonates. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2012
APA
Fernandes, R., Ribeiro, A. G., & Kano, E. K. (2012). Osteonecrosis of jaw in use of bisphosphonates. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Fernandes R, Ribeiro AG, Kano EK. Osteonecrosis of jaw in use of bisphosphonates. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 99 res. FCF193.[citado 2024 nov. 04 ]
Vancouver
Fernandes R, Ribeiro AG, Kano EK. Osteonecrosis of jaw in use of bisphosphonates. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 99 res. FCF193.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Adverse drug reactions of liraglutide and exenatide: Anoverview in pharmacovigilance (2012)
Castanho, Milenna; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Assunto: FARMACOVIGILÂNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTANHO, Milenna e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Adverse drug reactions of liraglutide and exenatide: Anoverview in pharmacovigilance. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2012
APA
Castanho, M., Ribeiro, A. G., & Kano, E. K. (2012). Adverse drug reactions of liraglutide and exenatide: Anoverview in pharmacovigilance. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Castanho M, Ribeiro AG, Kano EK. Adverse drug reactions of liraglutide and exenatide: Anoverview in pharmacovigilance. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 26 res. FCF048.[citado 2024 nov. 04 ]
Vancouver
Castanho M, Ribeiro AG, Kano EK. Adverse drug reactions of liraglutide and exenatide: Anoverview in pharmacovigilance. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 26 res. FCF048.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan (2012)
Rodrigues, Lara cheliz; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Subjects: ANTICORPOS MONOCLONAIS, FARMACOVIGILÂNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Lara cheliz e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2012
APA
Rodrigues, L. cheliz, Ribeiro, A. G., & Kano, E. K. (2012). Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Rodrigues L cheliz, Ribeiro AG, Kano EK. Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 27 res. FCF049.[citado 2024 nov. 04 ]
Vancouver
Rodrigues L cheliz, Ribeiro AG, Kano EK. Natalizumab associated to progressive multifocal leukoencephalopathy: Proposal to establish a risk minimization plan. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 27 res. FCF049.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment (2012)
Villa, Kamilla Fernandes; Ribeiro, Adalton Guimarães; Kano, Eunice Kazue
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Subjects: ESCLEROSE MÚLTIPLA, INTERFERON TIPO I
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILLA, Kamilla Fernandes e RIBEIRO, Adalton Guimarães e KANO, Eunice Kazue. Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2012
APA
Villa, K. F., Ribeiro, A. G., & Kano, E. K. (2012). Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Villa KF, Ribeiro AG, Kano EK. Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 5 res. FCF005.[citado 2024 nov. 04 ]
Vancouver
Villa KF, Ribeiro AG, Kano EK. Adverse drug reactions related to use of interferon beta-1A, interferon beta-1B and glatiramer for multiple sclerosis treatment. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 5 res. FCF005.[citado 2024 nov. 04 ]

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Conference titles

Non normalized affiliation